Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combining bioinformatics, network pharmacology and artificial intelligence to predict the target genes of S-ketamine for treating major depressive disorder. | J Psychopharmacol | 2025 | 39118379 | PubTator, text mining | PubMed |
| Systematic Mendelian Randomization Exploring Druggable Genes for Hemorrhagic Strokes. | Mol Neurobiol | 2025 | 38977622 | PubTator, text mining | PubMed |
| Special Issue "Adenosine Receptors in Health and Disease". | Int J Mol Sci | 2024 | 39596434 | PubTator, text mining | PubMed |
| The Inhibitory Effect of Hedera helix and Coptidis Rhizome Mixture in the Pathogenesis of Laryngopharyngeal Reflux: Cleavage of E-Cadherin in Acid-Exposed Primary Human Pharyngeal Epithelial Cells. | Int J Mol Sci | 2024 | 39596310 | PubTator, text mining | PubMed |
| Efficacy and safety of Piclidenoson in the treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials. | Arch Dermatol Res | 2024 | 39549073 | PubTator, text mining | PubMed |
| Structural insights into the agonist selectivity of the adenosine A3 receptor. | Nat Commun | 2024 | 39511145 | Swiss-Prot, curated | PubMed |
| Synthesis and biological evaluation of sugar-modified truncated carbanucleosides as A2A and A3 adenosine receptor ligands to explore conformational effect to the receptors. | Bioorg Med Chem | 2024 | 39504593 | PubTator, text mining | PubMed |
| Uncovering the therapeutic potential of green pea waste in breast cancer: a multi-target approach utilizing LC-MS/MS metabolomics, molecular networking, and network pharmacology. | BMC Complement Med Ther | 2024 | 39482666 | PubTator, text mining | PubMed |
| The association of gene polymorphisms of adenosine and dopamine receptors with the response to caffeine citrate treatment in infants with apnea of prematurity: a prospective nested case-control study. | Ital J Pediatr | 2024 | 39468580 | PubTator, text mining | PubMed |
| Stereochemical influence of 4'-methyl substitutions on truncated 4'-thioadenosine derivatives: Impact on A3 adenosine receptor binding and antagonism. | Bioorg Chem | 2024 | 39447347 | PubTator, text mining | PubMed |
| Structure-Activity Relationship of Truncated 4'-Selenonucleosides: A3 Adenosine Receptor Activity and Binding Selectivity. | ACS Med Chem Lett | 2024 | 39420956 | PubTator, text mining | PubMed |
| Electroacupuncture Relieves Neuropathic Pain via Adenosine 3 Receptor Activation in the Spinal Cord Dorsal Horn of Mice. | Int J Mol Sci | 2024 | 39408573 | PubTator, text mining | PubMed |
| Selective modulation of epileptic tissue by an adenosine A3 receptor-activating drug. | Br J Pharmacol | 2024 | 39300608 | PubTator, text mining | PubMed |
| Advances in psoriasis research: From pathogenesis to therapeutics. | Life Sci | 2024 | 39153596 | PubTator, text mining | PubMed |
| New and emerging oral therapies for psoriasis. | Drugs Context | 2024 | 39131603 | PubTator, text mining | PubMed |
| ADORA3 activation promotes goblet cell differentiation via enhancing HMGCS2-mediated ketogenesis in ulcerative colitis. | Int Immunopharmacol | 2024 | 39098229 | PubTator, text mining | PubMed |
| Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor. | J Med Chem | 2024 | 39073853 | PubTator, text mining | PubMed |
| 2-Substituted (N)-Methanocarba A3 Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo Characterization. | ACS Pharmacol Transl Sci | 2024 | 39022354 | PubTator, text mining | PubMed |
| Lipid Trolling to Optimize A3 Adenosine Receptor-Positive Allosteric Modulators (PAMs). | J Med Chem | 2024 | 38959401 | PubTator, text mining | PubMed |
| Adenosine A3 Receptor: From Molecular Signaling to Therapeutic Strategies for Heart Diseases. | Int J Mol Sci | 2024 | 38891948 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers?page=4